FDA Drug Application (021016) for RELPAX by PFIZER IRELAND

Back to FDA Applications sponsored by PFIZER IRELAND

Application Number021016
Product Number001
FormTABLET;ORAL
DosageEQ 20MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRELPAX
Active IngredientELETRIPTAN HYDROBROMIDE

Active IngredientCount
List of drugs with Active Ingredient ELETRIPTAN HYDROBROMIDE2


Back to FDA Applications sponsored by PFIZER IRELAND